PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts

Cathy Zhang, Zhengming Yan, Cory L. Painter, Qin Zhang, Enhong Chen, Maria E. Arango, Kyle Kuszpit, Kenneth Zasadny, Max Hallin, Jill Hallin, Anthony Wong, Dana Buckman, Guizhen Sun, Ming Qiu, Kenna Anderes, James G. ChristensenClinical 2009 · DOI

Abstract

Docetaxel triggers mitotic spindle checkpoint activation at low concentrations and activates both the DNA damage checkpoint and the spindle checkpoint at high concentrations. In combination with docetaxel, PF-00477736 abrogates the mitotic checkpoint, as well as the DNA damage checkpoint, and results in sensitization to docetaxel. Chk1 inhibitor PF-00477736 offers a therapeutic potential for the enhancement of taxane therapy.
BibTeX
@inproceedings{zhang2009pf,
  author = {Cathy Zhang and Zhengming Yan and Cory L. Painter and Qin Zhang and Enhong Chen and Maria E. Arango and Kyle Kuszpit and Kenneth Zasadny and Max Hallin and Jill Hallin and Anthony Wong and Dana Buckman and Guizhen Sun and Ming Qiu and Kenna Anderes and James G. Christensen},
  title = {{PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts}},
  booktitle = {Clinical},
  year = {2009},
  doi = {10.1158/1078-0432.ccr-08-3272},
}

Loading related content...

Figure